Pharvaris N.V. (GETTEX:9EN) Financings

Pharvaris N.V.

Financings

RaiseDate
Public offering of ordinary shares and pre-funded warrants
Closed: US$201.2M raised · US$20 a share · Morgan Stanley +4
Dealers: Morgan Stanley (co-lead), Leerink Partners (co-lead), Cantor (co-lead), Oppenheimer & Co. (co-lead), Van Lanschot Kempen (co-lead)
Use of proceeds: R&D for late-stage clinical programs, hiring a US sales and marketing team and commercialization, working capital and general corporate purposes
Jul 24, 2025

Read by 6ix AI from the company's releases